Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Multi-level omics analysis of dystrophin loss and therapeutic restoration in a murine model

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): synthetic construct Mus musculus

PROVIDER: GSE64420 | GEO | 2015/09/24

SECONDARY ACCESSION(S): PRJNA270989

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Multi-level omics analysis of dystrophin loss and therapeutic restoration in a murine model

Project description:This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

2015-09-24 | E-GEOD-64420 | biostudies-arrayexpress

Multi-level omics analysis in a murine model of dystrophin loss and therapeutic restoration.

Project description: Not available

| S-EPMC4634378 | biostudies-literature

Multi-level omics analysis of dystrophin loss and therapeutic restoration in a murine model [microRNA]

Project description:Duchenne muscular dystrophy (DMD) is a classical monogenic disorder, a model disease for genomic studies and a priority candidate for regenerative medicine and gene therapy. Although the genetic cause of DMD is well known, the molecular pathogenesis of disease and the response to therapy are incompletely understood. Here, we describe analyses of protein, mRNA and microRNA expression in the tibialis anterior of the mdx mouse model of DMD. Notably, 3272 proteins were quantifiable and 525 identified as differentially expressed in mdx muscle (P < 0.01). Therapeutic restoration of dystrophin by exon skipping induced widespread shifts in protein and mRNA expression towards wild-type expression levels, whereas the miRNome was largely unaffected. Comparison analyses between datasets showed that protein and mRNA ratios were only weakly correlated (r = 0.405), and identified a multitude of differentially affected cellular pathways, upstream regulators and predicted miRNA–target interactions. This study provides fundamental new insights into gene expression and regulation in dystrophic muscle. 3 Wt, 4 mdx and 4 Pip6e-PMO treated mdx mice

2015-09-24 | E-GEOD-64419 | biostudies-arrayexpress

Multi-level omics analysis of gene expression in a murine model of dystrophin loss and therapeutic restoration [mRNA]

Project description:Duchenne muscular dystrophy (DMD) is a classical monogenic disorder, a model disease for genomic studies and a priority candidate for regenerative medicine and gene therapy. Although the genetic cause of DMD is well known, the molecular pathogenesis of disease and the response to therapy are incompletely understood. Here,we describe analyses of protein, mRNA and microRNA expression in the tibialis anterior of the mdx mouse model of DMD. Notably, 3272 proteins were quantifiable and 525 identified as differentially expressed in mdx muscle (P < 0.01). Therapeutic restoration of dystrophin by exon skipping induced widespread shifts in protein and mRNA expression towards wild-type expression levels, whereas the miRNome was largely unaffected. Comparison analyses between datasets showed that protein and mRNA ratios were only weakly correlated (r = 0.405), and identified a multitude of differentially affected cellular pathways, upstream regulators and predicted miRNA–target interactions. This study provides fundamental new insights into gene expression and regulation in dystrophic muscle. 3 Wt, 4 mdx and 4 Pip6e-PMO treated mdx mice

2015-09-24 | E-GEOD-64418 | biostudies-arrayexpress

Multi-level omics analysis of dystrophin loss and therapeutic restoration in a murine model [microRNA]

2015-09-24 | GSE64419 | GEO

Multi-level omics analysis of gene expression in a murine model of dystrophin loss and therapeutic restoration [mRNA]

Project description:Duchenne muscular dystrophy (DMD) is a classical monogenic disorder, a model disease for genomic studies and a priority candidate for regenerative medicine and gene therapy. Although the genetic cause of DMD is well known, the molecular pathogenesis of disease and the response to therapy are incompletely understood. Here,we describe analyses of protein, mRNA and microRNA expression in the tibialis anterior of the mdx mouse model of DMD. Notably, 3272 proteins were quantifiable and 525 identified as differentially expressed in mdx muscle (P < 0.01). Therapeutic restoration of dystrophin by exon skipping induced widespread shifts in protein and mRNA expression towards wild-type expression levels, whereas the miRNome was largely unaffected. Comparison analyses between datasets showed that protein and mRNA ratios were only weakly correlated (r = 0.405), and identified a multitude of differentially affected cellular pathways, upstream regulators and predicted miRNA–target interactions. This study provides fundamental new insights into gene expression and regulation in dystrophic muscle.

2015-09-24 | GSE64418 | GEO

Multi-level omics analysis of dystrophin loss and therapeutic restoration in a murine model

Project description:Multi-level omics analysis of dystrophin loss and therapeutic restoration in a murine model

| PRJNA270989 | ENA

Deletion of miR-146a enhances therapeutic protein restoration in model of dystrophin exon skipping.

Project description: Not available

| S-EPMC11225849 | biostudies-literature

Deletion of miR-146a enhances therapeutic protein restoration in model of dystrophin exon skipping.

Project description: Not available

| S-EPMC10197665 | biostudies-literature

Multi-Omics Characterization of the 4T1 Murine Mammary Gland Tumor Model.

Project description: Not available